BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20308235)

  • 1. The neurofibromatoses.
    Ferner RE
    Pract Neurol; 2010 Apr; 10(2):82-93. PubMed ID: 20308235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis versus schwannomatosis].
    Mautner VF; Schröder S; Pulst SM; Ostertag H; Kluwe L
    Fortschr Neurol Psychiatr; 1998 Jun; 66(6):271-7. PubMed ID: 9676422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck manifestations of neurofibromatosis.
    Muecke M; Amedee RG
    J La State Med Soc; 1994 May; 146(5):183-6. PubMed ID: 8027629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The different forms of neurofibromatosis.
    Ruggieri M
    Childs Nerv Syst; 1999 Jul; 15(6-7):295-308. PubMed ID: 10461778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwannomatosis: the overlooked neurofibromatosis?
    Koontz NA; Wiens AL; Agarwal A; Hingtgen CM; Emerson RE; Mosier KM
    AJR Am J Roentgenol; 2013 Jun; 200(6):W646-53. PubMed ID: 23701098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis.
    Korf BR
    Handb Clin Neurol; 2013; 111():333-40. PubMed ID: 23622184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
    Ferner RE
    Lancet Neurol; 2007 Apr; 6(4):340-51. PubMed ID: 17362838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difficulties of the management of head and neck neurofibromatosis].
    Jeblaoui Y; Neji B; Haddad S; Mnif D; Hchicha S
    Ann Chir Plast Esthet; 2007 Feb; 52(1):43-50. PubMed ID: 17137698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis: part 2--clinical management.
    Batista PB; Bertollo EM; Costa Dde S; Eliam L; Cunha KS; Cunha-Melo JR; Darrigo Junior LG; Geller M; Gianordoli-Nascimento IF; Madeira LG; Mendes HM; Miranda DM; Mata-Machado NA; Morato EG; Pavarino ÉC; Pereira LB; Rezende NA; Rodrigues Lde O; Sette JB
    Arq Neuropsiquiatr; 2015 Jun; 73(6):531-43. PubMed ID: 26083891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eye involvement in neurofibromatosis].
    Baier M; Pitz S
    Ophthalmologe; 2016 May; 113(5):443-52. PubMed ID: 27142037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Segmental neurofibromatosis in children. Presentation of 43 patients].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; López-Gutiérrez JC
    Rev Neurol; 2008 Oct 16-31; 47(8):399-403. PubMed ID: 18937200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA.
    de Raedt T; Cools J; Debiec-Rychter M; Brems H; Mentens N; Sciot R; Himpens J; de Wever I; Schöffski P; Marynen P; Legius E
    Gastroenterology; 2006 Dec; 131(6):1907-12. PubMed ID: 17087943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polyneuropathy associated with neurofibromatosis].
    Drouet A; Créange A
    Rev Neurol (Paris); 2005 Mar; 161(3):275-83. PubMed ID: 15800448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Neurofibromatoses.
    Farschtschi S; Mautner VF; McLean ACL; Schulz A; Friedrich RE; Rosahl SK
    Dtsch Arztebl Int; 2020 May; 117(20):354-360. PubMed ID: 32657748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurofibromatoses. An overview.
    Ruggieri M; Huson SM
    Ital J Neurol Sci; 1999 Apr; 20(2):89-108. PubMed ID: 10933430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis types 1 and 2.
    Yohay K
    Neurologist; 2006 Mar; 12(2):86-93. PubMed ID: 16534445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.